Innovent Bio, Man Wah tap ECM for fresh funds
Innovent Biologics and Man Wah Holdings raised a combined HK$7.1bn ($916.3m) in fresh equity on Thursday night.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts